Methods of Treating Cancer with HDAC Inhibitors

Details for Australian Patent Application No. 2009201668 (hide)

Owner Merck HDAC Research, LLC

Inventors Richon, Victoria M.; Chiao, Judy H.; Bacopoulos, Nicholas G.; Paradise, Carolyn M.; Miller, Thomas A.

Agent Cullen & Co

Pub. Number AU-A-2009201668

Priority 10/692,523 24.10.03 US

Filing date 22 April 2009

Wipo publication date 21 May 2009

International Classifications

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

14 May 2009 Complete Application Filed

  Priority application(s): 10/692,523 24.10.03 US

21 May 2009 Application Open to Public Inspection

  Published as AU-A-2009201668

16 July 2009 Standard Patent Sealed

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009201669-Apparatus and method for vascular embolization

2009201665-Chimeric bird from embyonic stem cells